Navigation Links
New drug target in obesity: Fat cells make lots of melanin
Date:10/29/2008

As millions of Americans gear up for the Thanksgiving holiday, a new research report published online in The FASEB Journal (http://www.fasebj.org), may provide some relief for those leery of having a second helping. In the report, researchers describe a discovery that may allow some obese people avoid common obesity-related metabolic problems without actually losing weight: they make a common antioxidant, melanin, in excess. Even more promising is that some of the antioxidant drugs that can mimic the melanin effect are FDA-approved and available. This availability would greatly speed the development of new treatments, should they prove effective in clinical trials.

The researchers made the unexpected discovery--fat cells in obese people produce melanin in excess--when they were comparing fat cells of obese people to those of people with normal weight. After the comparison, they found that the gene responsible for making melanin was working in "overdrive" in the fat cells of obese people. The finding was then confirmed using additional laboratory tests. Melanin is a common antioxidant responsible for skin and eye color.

Ancha Baranova, one of the study's researchers from George Mason University and INOVA Fairfax Hospital says, "Most scientific efforts aim at making obese individuals lose weight, but this has proven difficult. Hopefully, this study will lead to a drug that keeps obese individuals healthy, reducing the cost-burden to society as well as some of the stigma associated with this condition."

According to the U.S. Centers for Disease Control and Prevention, the prevalence of obesity in 2005� was about 1 in 3 for men and women. Obesity increases the risk of diseases and health conditions, such as high blood pressure, osteoarthritis, dyslipidemia, Type 2 diabetes, coronary heart disease, stroke, gallbladder disease, sleep apnea and respiratory problems, and some cancers.

"No pill can replace a healthy diet and exercise, yet," said Gerald Weissmann, MD, Editor-in-Chief of The FASEB Journal, "but this could be a major advance for physicians looking for a safe drug target in their search to keep obese patients healthy while their weight becomes normal."


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related medicine news :

1. What Boomers Need to Know About Digestion; Enzymatic Therapy's CompleteGest1 Renew targets special digestive issues
2. A potential targets for the prevention or treatment of esophageal carcinoma
3. Preliminary Clinical Data Presented at the 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrate Superior Profile of S*BIOs Novel Anti-Cancer Drug SB939
4. Vista Partners Updates Coverage on MediciNova Inc. (NASDAQ: MNOV); Maintains $8.50 Price Target
5. Samplify Evolves Business Model From IP Developer to Semiconductor Supplier; Now Targets Multi-Billion Dollar Market
6. Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C.
7. Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms
8. Annual report targets chronic kidney disease in the United States
9. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
10. Breast Cancer Action Targets Yoplait in Think Before You Pink Campaign; Calls for Yogurt Without Artificial Hormones
11. World Alzheimer's Day 2008 Special Report: New Alzheimer Targets Take Center Stage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... and infrastructure. Most providers, however, are unsure how to move forward, given the ... to define a path forward tailored to an organization’s specific needs. , PYA ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
(Date:6/23/2016)... 23, 2016  Delcath Systems, Inc. (NASDAQ: ... focused on treatment of primary and metastatic liver cancers, ... education - www.againsttheodds.eu - has been awarded ... Awards. The website was developed ... and their families who are coping with the devastating ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. Stock-Callers.com has initiated coverage on the following equities: ... (NASDAQ: AMAG ), IDEXX Laboratories Inc. (NASDAQ: ... ADRO ). Learn more about these stocks by accessing their ...
Breaking Medicine Technology: